Normal saline placebo
Normal saline placebo is a pharmaceutical drug with 72 clinical trials. Currently 19 active trials ongoing. Historical success rate of 90.2%.
Success Metrics
Based on 37 completed trials
Phase Distribution
Phase Distribution
17
Early Stage
17
Mid Stage
25
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
86.0%
37 of 43 finished
14.0%
6 ended early
19
trials recruiting
72
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Cerebrolysin After Reperfusion in Extended-window EndoVascular Thrombectomy
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Early Intravenous Hydrocortisone in Sepsis
Administration Of Calcium Gluconate for The Reduction of Blood Loss During Vaginal Delivery
Intra-Articular PRP Versus Dexamethasone for TMJ Internal Derangement
Clinical Trials (72)
Cerebrolysin After Reperfusion in Extended-window EndoVascular Thrombectomy
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Early Intravenous Hydrocortisone in Sepsis
Administration Of Calcium Gluconate for The Reduction of Blood Loss During Vaginal Delivery
Intra-Articular PRP Versus Dexamethasone for TMJ Internal Derangement
Effectiveness of Single and Dual Silver Fluoride Application
Topical Tranexamic Acid to Reduce Blood Loss During Cesarean Delivery
Safety, Tolerability and Efficacy of PfSPZ-LARC2 Vaccine Against CHMI in Malaria-Naïve Adults
SkyVaricella® (NBP608) Vaccine With Lower Potencies in Healthy Children Aged 12 Months to 12 Years
Effect of Dexmedetomidine on Acute Kidney Injury After Ascending Aortic Surgeries
Continuous Serratus Anterior Blockade for Sternotomy
DMID 23-0015; Lassa Fever CVD 1000
rhBNP for Prevention of Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI)
Intravesical Aminophylline to Facilitate Ureteroscopic Access in Children With Distal Ureteral Stones.
A Phase 1/2a to Evaluate the Safety and Efficacy of Adipose Tissue Allograft (BRC-OA) in Patients With Osteoarthritis of the Knee
Impact of Prophylactic Ephedrine on Fetal Heart Tracing and Uterine Tetanic Contraction After CSE
Safety and Preliminary Efficacy of hUCMSC-EVs in Interstitial Lung Disease
Effect of Ipratropium Bromide on EILO
Age De-escalation Safety Trial of PfSPZ-LARC2 Vaccine in Burkina Faso
Application of Low-dose Muscle Relaxants in Bronchoscopic Interventional Procedures
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 72